Skip to Main Content
Legislation Search

S. 2150: Women’s Health Protection Act of 2025

This bill, known as the Women's Health Protection Act of 2025, aims to secure and protect a person's right to seek and obtain abortion services. Its major provisions can be summarized as follows:

Purpose of the Act

  • To allow individuals to obtain abortion services and enable healthcare providers to offer such services without facing excessive restrictions or regulations that do not apply to similar medical procedures.
  • To uphold women's ability to partake equally in social and economic life by ensuring access to abortion services.
  • To defend people's autonomy over their own bodies and health decisions.
  • To remove unnecessary barriers that could hinder interstate commerce and travel related to seeking abortion services.

Definitions

  • Abortion services: This includes any medical or non-medical services associated with providing an abortion.
  • Health care provider: This term covers various entities and individuals involved in delivering health care, including hospitals, clinics, and licensed professionals.
  • Viability: This refers to the stage in pregnancy when a fetus can survive outside the womb, as determined by medical judgment.

Rights Protected by the Act

The Act outlines specific rights for healthcare providers and patients:

  • Pre-viability: Patients can seek abortions without facing prohibitions or restrictions before the fetal viability stage. This includes limiting methods or requiring unnecessary procedures before receiving an abortion.
  • Post-viability: Abortion is permitted if deemed necessary to protect the patient's life or health; states may add additional circumstances for post-viability abortions.
  • Healthcare providers cannot impose medically inaccurate information or require multiple unnecessary visits for abortion services.
  • Patients cannot be discriminated against based on their state of residency when seeking services.

Protection of Travel

The legislation affirms a person’s right to travel between states to obtain reproductive health services, including abortions, and to assist others in doing so.

Applicability and Legal Authority

  • This Act supersedes any conflicting federal or state laws, preventing officials from enforcing restrictions that violate the Act.
  • Exceptions include regulations governing physical access to clinics and certain aspects of medical coverage for abortion services.

Enforcement

There are provisions for enforcing the Act, allowing:

  • The Attorney General to take civil action against states or officials who violate the Act.
  • Individuals adversely affected by violations to file civil suits against officials implementing conflicting limitations.

Legal Protections and Remedies

  • The Act stipulates courts should interpret its provisions liberally to achieve the intended protections.
  • In any enforcement action, prevailing plaintiffs may be awarded legal costs, and provisions ensure that government officials cannot claim immunity from actions challenging violations of the Act.

Severability Clause

If any part of this Act is found to be unconstitutional, the remainder of the Act will remain effective.

Effective Date

The Act will take effect immediately upon enactment.

Relevant Companies

  • AMGN (Amgen Inc.): May be impacted due to potential changes in the market for healthcare services related to reproductive health and pharmaceuticals.
  • TEVA (Teva Pharmaceutical Industries): As a supplier of medical products, could see changes in demand based on the accessibility of healthcare services under the new regulations.
  • ABMD (Abiomed, Inc.): Might be affected by shifts in healthcare provider regulations and operational costs concerning abortion service provisions.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

47 bill sponsors

Actions

2 actions

Date Action
Jun. 24, 2025 Introduced in Senate
Jun. 24, 2025 Read twice and referred to the Committee on the Judiciary.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Cliff Bentz R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 06, 2025 -1.52%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 19, 2025 May 14, 2025 +7.39%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $15,001 - $50,000
Jun 22, 2025 May 12, 2025 +1.42%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -4.32%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -13.23%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -13.23%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $15,001 - $50,000
May 15, 2025 Apr 15, 2025 -15.13%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -12.69%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 09, 2025 -12.51%
Congress pfp
Robert Bresnahan R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -19.19%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -8.21%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -0.50%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +6.09%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +10.44%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +6.65%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -1.44%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 12, 2024 -4.80%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -14.95%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 11, 2024 -16.86%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -21.21%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Oct 04, 2024 Sep 09, 2024 -22.70%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN C�������: OUR BROKER PURCHASED SHARES OF 29 STOCKS IN MY SPOUSE'S ROTH IRA ON 8/7/24 IN ORDER TO REBALANCE THE PORTFOLIO IN ACCORDANCE WITH THE FIRM'S INVESTMENT STRATEGY FOR ACCOUNTS THAT SIZE. HE FAILED TO NOTIFY ME OF THESE TRANSACTIONS AND IT WASN'T DISCOVERED UNTIL I WAS ATTEMPTING TO RECONCILE OUR INVESTMENT HOLDINGS FOR MY 2024 FINANCIAL DISCLOSURE. SP AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 03, 2025 Aug 07, 2024 -24.91%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -24.91%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -27.77%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -27.77%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -27.77%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -17.74%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -17.74%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -17.98%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -32.45%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -32.47%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -31.85%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -39.32%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -35.16%